Evidence map›Paper›PMID 36381571›Full record

ArticleGlobal health & medicine2022

Implementation of two novel schemes for patients on dialysis as a response to the COVID-19 surge in Tokyo.

Keisuke Naito, Kan Kikuchi, Yu Watanabe, Tomoyo Narita

Open access · bronzeAbstract readEditorial
In one paragraph

Article in Global health & medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Keisuke NaitoBureau of Social Welfare and Public Health, Tokyo Metropolitan Government, Japan.
Kan KikuchiDivision of Nephrology, Shimoochiai Clinic, Tokyo, Japan.
Yu WatanabeBureau of Social Welfare and Public Health, Tokyo Metropolitan Government, Japan.
Tomoyo NaritaBureau of Social Welfare and Public Health, Tokyo Metropolitan Government, Japan.
Tokyo Metropolitan Government · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Japanese government recommended hospitalization of patients on dialysis once they tested positive because of their high COVID-19 mortality rate and definite need for periodic dialysis. However, after experiencing the Delta variant surge, strategic changes towards outpatient care for mild or asymptomatic cases, along with strengthening emergency preparedness were needed. Facing the Omicron surge, the Tokyo Metropolitan Government introduced two novel schemes:

Indexed as

emergency preparednessmaintaining essential health servicespolicy

Identifiers

PMID36381571
PMCPMC9619119
OpenAlexW4309244216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.